Professional Documents
Culture Documents
Case Study 2 Pedia
Case Study 2 Pedia
GARANCHON BSN2E
Objectives:
This presentation aims to:
1.Present the patient’s profile, including the patient’s history, to
determine the nature of underlying problems.
2.Discuss the normal findings of physical assessment.
3.Understand the disease pathophysiology and etiology of the
case being presented.
4.Understand the role of drug therapy in managing the client in
relation to the diagnosis.
5.Present data in relation to the case.
6.Effectively provide appropriate nursing diagnosis with regards to
client’s condition and develop a nursing care plan for the identified
problem.
7.Apply effective nursing interventions which are necessary for
the client’s condition.
Patient’s Profile:
Patient's name: Age: 12 years old Sex: Male Birthday: Not indicated
Physical Assessment
Client’s admission assessment reveals:
-pharynx has moderate lymphoid hypertrophy. He has multiple small lymph nodes
palpable in his upper neck.
Parameter
Temperature 38.1,
Heart Rate
BP 85/65,
PATHOPHYSIOLOGY
➦ ➦
➥ ➥ ↵
↳ ↔ ↲
↳ ↲
Montelukast
Nebulized Corticosteroids
Mechanism Of Drug Indication Drug Adverse Effects
Action Contraindication
help reverse the Inhaled These include Local adverse
pathologic process of corticosteroids (ICS) hypersensitivity to
bronchial asthma.
effects of inhaled
are the the medication and
Corticosteroids FDA-indicated
corticosteroids
enhance the severe include
treatment of choice hypersensitivity to
beta-adrenergic
in preventing dysphonia, oral
response to relieve the
muscle spasm. They asthma milk candidiasis,
also act by reversing exacerbations in proteins/lactose.
the mucosal edema,
reflex cough, and
patients with Dry powder
decreasing vascular persistent
bronchospasm.
permeability by inhalers often These adverse
asthma.[1] contain lactose as
vasoconstriction, and
Persistent asthma is effects are less
inhibiting the release of a stabilizing agent.
LTC4 and LTD4. classified by common with
symptoms more Though not
Corticosteroids reduce
intentional, there
low-dose inhaled
the mucus secretion by than two days a corticosteroids
inhibiting the release of week, more than have been reports
secretagogue from three nighttime of milk protein than with
macrophages. awakenings per contamination high-dose
Corticosteroids inhibit month, more than within inhaled
the late phase reaction
by inhibiting the
twice a week using lactose-containing corticosteroids.
inflammatory response
short-acting beta-2 medications, These adverse
and interfering with agonists for including dry effects are also
chemotaxis symptom control, or powdered
any limitation of mitigated by
inhalers.[18] spacer use when
normal activity due
to asthma.[1]
Therefore, in taking the
Regular use of these patients with medication via
medications reduces severe milk protein
metered-dose
the frequency of or lactose
allergies, DPI inhalers.
asthma symptoms,
bronchial asthma
hyperresponsivenes medications are
s, risk of serious contraindicated.
exacerbations and Additional
improves the quality contraindications
of life.[2] These include untreated
medications are
fungal, bacterial,
initiated in a
stepwise fashion and tubercular
based on the infections of the
frequency and respiratory tract.
severity of the Inhaled
asthma symptoms. corticosteroids are
Low, medium, and recommended
high-dose inhaled therapy for treating
corticosteroids are asthma during
available to treat pregnancy.
mild, moderate, and Maternal ICS use
severe persistent
during pregnancy
asthma,
respectively.[3] If
has not
inhaled demonstrated an
corticosteroids alone increase in the risk
are not adequate in of congenital
controlling a malformations or
patient's asthma impaired fetal
symptoms, other growth
controller
medications such as
long-acting
beta-agonists or
leukotriene receptor
antagonists may
also be started.
Asthma controller
medications often
are used in
conjunction with
short-acting
beta-agonists such
as albuterol as part
of an asthma action
plan to address
acute and chronic
symptoms.[
Nebulized Cromolyn
Mechanism Of Drug Indication Drug Adverse Effects
Action Contraindication
Cromolyn sodium is a Hypersensitivity
mast cell stabilizer The frequency of
● Cromolyn to cromolyn adverse effects
that prevents the
sodium is an products or remains unclear.
subsequent release of
FDA-approve components of the Adverse effects vary
inflammatory
mediators, including d medication formulation is the depending on the
histamine and used for absolute route of
leukotrienes, which prophylaxis of administration.
contraindications
cause allergic mild to
symptoms and moderate for the use of The ophthalmic
bronchoconstriction. bronchial cromolyn sodium. solution may
It inhibits mast cell asthma and correlate with
degranulation, adjunctive transient burning of
normally implicated treatment of eyes upon
in anaphylaxis allergic administration, eye
following exposure to rhinitis and dryness, puffiness,
reactive allergens. systemic mast irritation, itchiness,
Cromolyn sodium cell disease rash, and styes.
differs from (mastocytosis) Adverse events
antihistamine in pediatric associated with oral
medications, which patients and solution include
reduce the action of adults. It is nausea, vomiting,
histamines following not diarrhea, abdominal
the release from mast immediate-act pain, constipation,
cells. Unlike ing, has no erythema,
corticosteroids that direct photosensitivity,
inhibit the late bronchodilato urticaria, and
response of r effects, and angioedema. In
antigen-induced thus does not addition, there are
asthmatic reactions, treat acute reports of nasal
cromolyn sodium asthma congestion, sneezing,
inhibits immediate attacks. nasal itching,
and late ● It is also nosebleeds,
reactions.[10][6] The available as rhinoconjunctivitis,
use of cromolyn an ophthalmic and headaches with
sodium has been solution for the use of cromolyn
associated with the sodium nasal spray.
improvement in symptomatic
flushing, headaches, treatment of Additional adverse
diarrhea, vomiting, certain effects reported with
nausea, urticaria, allergic eye the inhalation
abdominal pain, and conditions solution were throat
itching in patients such as vernal irritation and
with mastocytosis. conjunctivitis, hoarseness,
keratitis, and esophagitis, laryngeal
keratoconjunc and pharyngeal
tivitis. edema, drowsiness,
dizziness, bronchial
irritation, pulmonary
infiltrates, and cough.